Testosterone supplementation did not show consistent benefit for cardiovascular risk , sexual function , mood and behavior , or cognition .
Studies that examined clinical cardiovascular endpoints have not favored testosterone therapy over placebo .
Testosterone is ineffective in treating erectile dysfunction and controlled trials did not show a consistent effect on libido .
Testosterone supplementation consistently increased muscle strength but did not have beneficial effects on physical function .
Most studies on mood-related endpoints found no beneficial effect of testosterone treatment on personality , psychological well-being , or mood .
Testosterone products are recommended by some prescribers in response to a diagnosis or presumption of " low testosterone " ( low-T ) for cardiovascular health , sexual function , muscle weakness or wasting , mood and behavior , and cognition .
Therapeutic effects of an androgenic preparation on myocardial ischemia and cardiac function in 62 elderly male coronary heart disease patients.
The elevated estradiol/testosterone ( E2/T ) ratio had been proved to be a risk factor for coronary heart disease ( CHD ) in elderly men . We conducted a r and omized placebo controlled crossover study on the effects of a new and rogenic preparation " And riol " in 62 elderly men with CHD over a period of 2.5 months . The results showed significant differences between And riol- and placebo-treated groups at the end of this period : in the former , serum T level was elevated significantly ( P < 0.001 ) , E2 level was unchanged ( P > 0.05 ) , E2/T ratio was reduced ( P < 0.05 ) , angina pectoris ( AP ) was relieved ( total effective rate , 77.4 % ) , and myocardial ischemia in ECG and Holter recordings were improved ( total effective rate , respectively 68.8 % and 75 % ) . Doppler echocardiography showed that 12 parameters of cardiac function were unchanged in both groups . No obvious side effect was found in those who took And riol
Testosterone supplementation did not show consistent benefit for cardiovascular risk , sexual function , mood and behavior , or cognition .
Studies that examined clinical cardiovascular endpoints have not favored testosterone therapy over placebo .
Testosterone is ineffective in treating erectile dysfunction and controlled trials did not show a consistent effect on libido .
Testosterone supplementation consistently increased muscle strength but did not have beneficial effects on physical function .
Most studies on mood-related endpoints found no beneficial effect of testosterone treatment on personality , psychological well-being , or mood .
Testosterone products are recommended by some prescribers in response to a diagnosis or presumption of " low testosterone " ( low-T ) for cardiovascular health , sexual function , muscle weakness or wasting , mood and behavior , and cognition .